Download PDF
Der Nuklearmediziner 2003; 26(3 ): 181-188
DOI: 10.1055/s-2003-44326
Nuklearmedizinische Nierendiagnostik

© Georg Thieme Verlag Stuttgart · New York

Nierenfunktionsbestimmungen mit Clearance: Methoden und Indikationen

Kidney Function Measured by Clearance: Methods and IndicationsR. Müller-Suur1 , E. Durand2
  • 1Karolinska Institut, Danderyds Krankenhaus, Stockholm, Schweden
  • 2Universitätskrankenhaus Bicetre, Paris, Frankreich
Further Information

Publication History

Publication Date:
20 November 2003 (online)

Also available at
    Permissions and Reprints

Corrected by:

ErratumDer Nuklearmediziner 2004; 27(01): 3-3
DOI: 10.1055/s-2004-820240

Zusammenfassung

Um die Nierenfunktion quantitativ zu beurteilen, gibt es viele Methoden. Meistens benutzten die Kliniker die simple Bestimmung des Plasmakreatinins; einige wählen jedoch die Kreatininclearance mit Urinsammlung oder andere alternative, aber indirekte, Methoden. Zur quantitativen Nierenfunktionsmessung ergibt die Isotopenclearance jedoch im Vergleich zu anderen Methoden eine hohe Genauigkeit, ist meist einfach durchzuführen und verursacht eine äußerst geringe Strahlenbelastung. In diesem Überblick werden die unterschiedlichen Radiopharmaka für die Isotopenclearance, deren Vor- und Nachteile, sowie der Clearancebegriff und die unterschiedlichen Clearancetechniken besprochen. Auch eine Zusammenstellung von klinisch wichtigen Indikationen wird genannt. Die Plasmaclearance mit 51-Cr-EDTA nach einmaliger Injektion und mit einer Plasmaprobe ist die meist empfohlene Methode. Bei gewissen speziellen klinischen Situationen empfehlen sich jedoch Modifikationen, die beschrieben werden.

Abstract

Renal function impairment can be monitored by many tests. Measurement of plasma-creatinine level is the most used method, 24 hour plasma-creatininclearance with urine collection is used by others and also other alternative but indirect methods exist. However, the use of radionuclide-clearances is by far the easiest performed method with the highest accuracy and precision and gives very low irradiation dose. In the following we will discuss the different radiopharmaceuticals in use, their plus and minus, the different clearance methods in use, their limitations and give some clinically important indications to perform clearance investigations according to consensus reports. Summarizing the use of plasma clearance of 51-Cr-EDTA after a single injection with one blood sample can be generally recommended, however with some modifications in special clinical situations, which are pointed out.

Schlüsselwörter

Clearance - GFR - Isotopenclearance - 51-Cr-EDTA-„slope”-Clearance - MAG-3-Clearance

Key words

Clearance - GFR - radionuclide clearance - 51-Cr-EDTA single injection clearance - MAG-3 clearance

Literatur

  • 1 Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement.  Lancet. 1986;  1 307-310
    PubMedGoogle Scholar
  • 2 Blaufox M D, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C. et al . Report of the Radionuclides in Nephrourology Committee on renal clearance.  J Nucl Med. 1996;  37 1883-1890
    PubMedGoogle Scholar
  • 3 Boyd E. Growth of the surface area of the human body. In: University of Minnesota Press, Minnesota 1935; 132
    Google Scholar
  • 4 Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate.  Scand J Clin Lab Invest. 1972;  30 271-274
    PubMedGoogle Scholar
  • 5 Brøchner-Mortensen J. Current status on assessment and measurement of glomerular filtration rate.  Clin Physiol. 1985;  5 1-17
    PubMedGoogle Scholar
  • 6 Brøchner-Mortensen J, Freund L G. Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency.  Scand J Clin Lab Invest. 1981;  41 91-97
    CrossrefPubMedGoogle Scholar
  • 7 Bubeck B. Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle.  Semin Nucl Med. 1993;  23 73-86
    CrossrefPubMedGoogle Scholar
  • 8 Bubeck B, Brandau W, Weber E, Kalble T, Parekh N, Georgi P. Pharmacokinetics of technetium-99m-MAG3 in humans.  J Nucl Med. 1990;  31 1285-1293
    PubMedGoogle Scholar
  • 9 Carlsen J E, Moller M L, Lund J O, Trap-Jensen J. Comparison of four commercial Tc-99m(Sn)DTPA preparations used for the measurement of glomerular filtration rate: concise communication.  J Nucl Med. 1980;  21 126-129
    PubMedGoogle Scholar
  • 10 Chantler C, Barratt T M. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid.  Arch Dis Child. 1972;  47 613-617
    PubMedGoogle Scholar
  • 11 Chantler C, Garnett E S, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.  Clin Sci. 1969;  37 169-180
    PubMedGoogle Scholar
  • 12 Christensen A B, Groth S. Determination of 99mTc-DTPA clearance by a single plasma sample method.  Clin Physiol. 1986;  6 579-588
    CrossrefPubMedGoogle Scholar
  • 13 Cockcroft D W, Gault M H. Prediction of creatinine clearance from serum creatinine.  Nephron. 1976;  16 31-41
    Google Scholar
  • 14 DuBois D, DuBois E. A formula to estimate the approximate surface area if height and weight are known.  Arch Int Med. 1916;  17 863-871
    PubMedGoogle Scholar
  • 15 Durand E, Prigent A. The basics of renal imaging and function studies.  Q J Nucl Med. 2002;  46 249-267
    PubMedGoogle Scholar
  • 16 Durand E, Prigent A, Gaillard J. Comparaison between 9 methods for estimation of glomerular filtration rate (G.F.R.) with simultaneous injections of 51Cr-EDTA and 99mTc-DTPA. In: Taylor A Jr, Nally J, Thomsen H (eds). Radionuclides in nephrology. Society of Nuclear Medicine, Reston 1997; 112-120
    Google Scholar
  • 17 Florijn K W, Barendregt J N, Lentjes E G, van Dam W, Prodjosudjadi W, van Saasa J L. et al . Glomerular filtration rate measurement by “single-shot” injection of inulin.  Kidney Int. 1994;  46 252-259
    CrossrefPubMedGoogle Scholar
  • 18 Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate.  Scand J Clin Lab Invest. 1981;  41 611-616
    CrossrefPubMedGoogle Scholar
  • 19 Groth S, Aasted M. 51Cr-EDTA clearance determined by one plasma sample in children.  Clin Physiol. 1984;  4 75-83
    PubMedGoogle Scholar
  • 20 Ham H R, Piepsz A. Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method.  J Nucl Med. 1991;  32 1294-1297
    PubMedGoogle Scholar
  • 21 Kamper A L, Nielsen S L. 51Cr-EDTA plasma clearance in severe renal failure determined by one plasma sample.  Scand J Clin Lab Invest. 1989;  49 555-559
    CrossrefPubMedGoogle Scholar
  • 22 LaFrance N D, Drew H H, Walser M. Radioisotopic measurement of glomerular filtration rate in severe chronic renal failure.  J Nucl Med. 1988;  29 1927-1930
    PubMedGoogle Scholar
  • 23 Levey A S. Use of glomerular filtration rate measurements to assess the progression of renal disease.  Semin Nephrol. 1989;  9 370-379
    PubMedGoogle Scholar
  • 24 Müller-Suur R. Radiopharmaceuticals: their intrarenal handling and localisation. In: Murray, Ell (eds). Nuclear Medicine in Clinical Diagnosis and Treatment. Churchill-Livingstone, Edinburgh 1998; Kapitel 22
    Google Scholar
  • 25 Müller-Suur R, Magnusson G, Bois-Svensson I, Jansson B. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.  Eur J Nucl Med. 1991;  18 28-31
    PubMedGoogle Scholar
  • 26 Piepsz A, Gordon I, Hahn K, Kolinska J, Kotzerke J, Sixt R. Determination of technetium-99m-mercaptoacetylglycine plasma clearance in children by means of a single blood sample: a multicenter study.  Eur J Nucl Med. 1993;  20 244-248
    PubMedGoogle Scholar
  • 27 Rehling M, Hyldstrup L, Henriksen J H. Arterio-venous concentration difference of [51Cr]EDTA after a single injection in man. Significance of renal function and local blood flow.  Clin Physiol. 1989;  9 279-288
    CrossrefPubMedGoogle Scholar
  • 28 Rehling M, Moller M L, Thamdrup B, Lund J O, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man.  Clin Sci. 1984;  66 613-619
    PubMedGoogle Scholar
  • 29 Rehling M, Nielsen S L, Marqversen J. Protein binding of 99mTc-DTPA, 51Cr-EDTA and 125I-iothalamate.  Nucl Med Commun. 1997;  18 324
    PubMedGoogle Scholar
  • 30 Russell C D. Optimum sample times for single-injection, multisample renal clearance methods.  J Nucl Med. 1993;  34 1761-1765
    PubMedGoogle Scholar
  • 31 Russell C D, Bischoff P G, Kontzen F N, Rowell K L, Yester M V, Lloyd L K. et al . Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection.  J Nucl Med. 1985;  26 1243-1247
    PubMedGoogle Scholar
  • 32 Russell C D, Bischoff P G, Rowell K L, Kontzen F, Lloyd L K, Tauxe W N. et al . Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication.  J Nucl Med. 1983;  24 722-727
    PubMedGoogle Scholar
  • 33 Russell C D, Taylor A, Eshima D. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.  J Nucl Med. 1989;  30 1955-1959
    PubMedGoogle Scholar
  • 34 Russell C D, Taylor A T, Dubovsky E V. Measurement of renal function with technetium-99m-MAG3 in children and adults.  J Nucl Med. 1996;  37 588-593
    PubMedGoogle Scholar
  • 35 Sapirstein L, Vidt D, Mandel M, Hanusek G. Volumes of distribution and clearances of intravenously injected creatinine in the dog.  Am J Physiol. 1955;  181 330-336
    PubMedGoogle Scholar
  • 36 Stacy B D, Thorburn G D. Chromium-51 ethylenediaminetetraacetate for estimation of globerular filtration rate.  Science. 1966;  152 1076-1077
    CrossrefPubMedGoogle Scholar
  • 37 Tauxe W, Dubovsky E. Nuclear medicine in clinical urology and nephrology. Appleton-Centring-Crifts, Norwalk 1985
    Google Scholar
  • 38 Tauxe W N, Dubovsky E V, Kidd T, Diaz F, Smith L R. New formulas for the calculation of effective renal plasma flow.  Eur J Nucl Med. 1982;  7 51-54
    PubMedGoogle Scholar
  • 39 Taylor A. Radionuclide renography: a personal approach.  Semin Nucl Med. 1999;  29 102-127
    CrossrefPubMedGoogle Scholar
  • 40 Taylor A, Hansen L, Eshima D, Malveaux E, Folks R, Shattuck L. et al . Comparison of technetium-99m-ll-EC isomers in rats and humans.  J Nucl Med. 1997;  38 821-826
    PubMedGoogle Scholar
  • 41 Watson W S. A simple method of estimating glomerular filtration rate.  Eur J Nucl Med. 1992;  19 827
    PubMedGoogle Scholar
  • 42 Zimmer A M, Pavel D G. Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals.  J Nucl Med. 1977;  18 1230-1233
    PubMedGoogle Scholar

Doz. R Müller-Suur

Karolinska Institutet Danderyds Hospital

Department of Clinical Physiology

18288 Stockholm

Sweden

Phone: +46-86/55 50

Fax: +46-86/2 59 35

Email: roland.muller-suur@fys.ds.sll.se

      >